TruScreen Group Limited
TruScreen Group Limited
Your view on TRU.AX
Overview
What the company does, where it operates, and who runs it.
About TruScreen Group Limited
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Martin Dillon
- Headquarters
- Equitable House, Auckland, AU, NZ
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Martin Dillon
- Headquarters
- Equitable House, Auckland, AU, NZ
Truscreen Group Limited, along with its various subsidiaries, specializes in the design, production, and distribution of innovative cancer detection equipment and systems.
The company's market presence extends globally, covering regions such as Mexico, China, Russia, Vietnam, Zimbabwe, Eastern Europe, and the Middle East/North Africa, among other international territories.
Central to its offerings is the TruScreen cervical cancer screening system, a sophisticated medical device engineered to identify precancerous and cancerous tissue on the cervix with immediate, real-time results.
Incorporated in 2013, the organization was originally known as TruScreen Limited before officially changing to Truscreen Group Limited in August 2020. Its corporate headquarters are situated in Auckland, New Zealand.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for TruScreen Group Limited, and the rating behind it. TRU.AX last traded at AUD 0.01; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for TruScreen Group Limited. Starting points for TruScreen Group Limited: beta -0.06 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for TruScreen Group Limited. TruScreen Group Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for TruScreen Group Limited. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for TruScreen Group Limited. TruScreen Group Limited has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
TruScreen Group Limited valued side by side against its closest peers. TruScreen Group Limited is measured against Medical - Devices peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold TruScreen Group Limited, and how their positions are changing. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by TruScreen Group Limited executives and directors. Shares of TruScreen Group Limited have traded between AUD 0.01 and AUD 0.03 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming TruScreen Group Limited. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming TruScreen Group Limited. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for TruScreen Group Limited. Coverage tracks TruScreen Group Limited within Medical - Devices (Healthcare). Press releases and market coverage, newest first.